Evaluation of Respiratory Functions with Spirometry in Patients with SARS-CoV-2 Pneumonia Pulmonary Function Tests in SARS-CoV-2 Pneumonia

Main Article Content

Tahsin Karaaslan
Esra Karaaslan
Omer Uysal
Mehmet Gunduz


Objective: This study aims to evaluate respiratory functions in patients Coronavirus disease-2019 (COVID-19) with and without pneumonia.

Material and Methods: This single-center, prospective study included a total of 72 patients who were diagnosed with COVID-19 infection as confirmed by real-time reverse transcriptase polymerase chain reaction (rtPCR). The patients were divided into two groups according to the physical and thoracic computed tomography (CT) findings as mild symptomatic patients without COVID-19 pneumonia (n=26) and symptomatic cases with COVID-19 pneumonia (n=46). Respiratory functions were evaluated by spirometry in the second and fourth months of the disease onset.

Results: The average age of 72 patients, 41 of whom were men, was 40.5±12.27 years. Thoracic CT revealed infiltrations compatible with COVID-19 pneumonia in 46 (63.9%) patients. Hypertension (12.5%) and diabetes (5.6%) were the most common comorbidities. When the results of the patients with and without pneumonia at the second and fourth months were compared, there was no significant difference between the forced expiratory volume in the first second (FEV1) (p1=0,975, p2=0,291), forced vital capacity (FVC) (p1=0,668,p2=0,481) and FEV1/FVC ratio (FER) (p1=0,378, p2=0,980) values. When the repeated anova test was used in the comparison of the two visit differences between the groups, it was seen that there was no difference in any heading (FVC: p=0.077; FEV1: p=0.150; FER: p=0.355).

Conclusions: Our study results show no significant difference in the pulmonary function tests of patients with mild and moderate COVID-19 pneumonia at two and four months, compared to those without pneumonia However, additional studies are needed for severe and critical cases.


Download data is not yet available.

Article Details

How to Cite
Karaaslan, T., Karaaslan, E., Uysal, O., & Gunduz, M. (2021). Evaluation of Respiratory Functions with Spirometry in Patients with SARS-CoV-2 Pneumonia. Medical Science and Discovery, 8(9), 538-545. https://doi.org/10.36472/msd.v8i9.597
Research Article


1. Chen X, Tian J, Li G, Li G. Initiation of a new infection control system for the COVID-19 outbreak. The Lancet Infectious diseases. 2020;20(4):397-8.

2. Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery (London, England). 2020;76:71-6.

3. Hui DS, Joynt GM, Wong KT, Gomersall CD, Li TS, Antonio G, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60(5):401-9.

4. Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology (Carlton, Vic). 2010;15(3):543-50.

5. Park WB, Jun KI, Kim G, Choi JP, Rhee JY, Cheon S, et al. Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. Journal of Korean medical science. 2018;33(24):e169.

6. Mason RJ. Pathogenesis of COVID-19 from a cell biology perspective. The European respiratory journal. 2020;55(4).

7. Hariri LP, North CM, Shih AR, Israel RA, Maley JH, Villalba JA, et al. Lung Histopathology in Coronavirus Disease 2019 as Compared With Severe Acute Respiratory Sydrome and H1N1 Influenza: A Systematic Review. Chest. 2021;159(1):73-84.

8. Townsend MC. The American Thoracic Society/European Respiratory Society 2019 Spirometry Statement and Occupational Spirometry Testing in the United States. American journal of respiratory and critical care medicine. 2020;201(8):1010-1.

9. Ulubay G, Köktürk N, Görek Dilektaşlı A, Şen E, Çiftci F, Demir T, et al. [Turkish Thoracic Society national spirometry and laboratory standards]. Tuberkuloz ve toraks. 2017;65(2):117-30.

10. Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiological genomics. 2020;52(11):549-57.

11. Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;12(3):e7355.

12. Zheng Q, Lu Y, Lure F, Jaeger S, Lu P. Clinical and radiological features of novel coronavirus pneumonia. Journal of X-ray science and technology. 2020;28(3):391-404.

13. Zitek T. The Appropriate Use of Testing for COVID-19. The western journal of emergency medicine. 2020;21(3):470-2.

14. Winichakoon P, Chaiwarith R, Liwsrisakun C, Salee P, Goonna A, Limsukon A, et al. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19. Journal of clinical microbiology. 2020;58(5).

15. Xie J, Ding C, Li J, Wang Y, Guo H, Lu Z, et al. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. Journal of medical virology. 2020;92(10):2004-10.

16. Ulubay G, Dilektaşlı AG, Börekçi Ş, Yıldız Ö, Kıyan E, Gemicioğlu B, et al. Turkish Thoracic Society Consensus Report: Interpretation of Spirometry. Turkish thoracic journal. 2019;20(1):69-89.

17. Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory medicine. 2020;8(4):420-2.

18. Hanley B, Lucas SB, Youd E, Swift B, Osborn M. Autopsy in suspected COVID-19 cases. Journal of clinical pathology. 2020;73(5):239-42.

19. Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China. European radiology. 2020;30(6):3306-9.

20. Bell TJ, Brand OJ, Morgan DJ, Salek-Ardakani S, Jagger C, Fujimori T, et al. Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis. Matrix biology : journal of the International Society for Matrix Biology. 2019;80:14-28.

21. Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral research. 2017;143:142-50.

22. Kuang D, Xu SP, Hu Y, Liu C, Duan YQ, Wang GP. [Pathological changes with novel coronavirus infection in lung cancer surgical specimen]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2020;49(5):471-3.

23. Pernazza A, Mancini M, Rullo E, Bassi M, De Giacomo T, Rocca CD, et al. Early histologic findings of pulmonary SARS-CoV-2 infection detected in a surgical specimen. Virchows Archiv : an international journal of pathology. 2020;477(5):743-8.

24. Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020;15(5):700-4.

25. Cai Y, Hao Z, Gao Y, Ping W, Wang Q, Peng S, et al. Coronavirus Disease 2019 in the Perioperative Period of Lung Resection: A Brief Report From a Single Thoracic Surgery Department in Wuhan, People's Republic of China. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2020;15(6):1065-72.

26. Zha L, Shen Y, Pan L, Han M, Yang G, Teng X, et al. Follow-up study on pulmonary function and radiological changes in critically ill patients with COVID-19. The Journal of infection. 2021;82(1):159-98.

27. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.

28. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. The European respiratory journal. 2020;55(6).

29. Liu K, Zhang W, Yang Y, Zhang J, Li Y, Chen Y. Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complementary therapies in clinical practice. 2020;39:101166.

30. Frija-Masson J, Debray MP, Gilbert M, Lescure FX, Travert F, Borie R, et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. The European respiratory journal. 2020;56(2).

31. Bennett S, Tafuro J, Mayer J, Darlington D, Wong CW, Muntean EA, et al. Clinical features and outcomes of adults with coronavirus disease 2019: A systematic review and pooled analysis of the literature. International journal of clinical practice. 2020:e13725.

32. Karaaslan T, Karatoprak C, Karaaslan E, Sasak Kuzgun G, Gunduz M, Sekerci A, et al. Markers predicting critical illness and mortality in COVID-19 patients: A multi-centre retrospective study. Ann Clin Anal Med. 2021;12:159-65.